Infliximab therapy for inflammatory colitis in an infant with NEMO deficiency

Immunol Res. 2019 Oct;67(4-5):450-453. doi: 10.1007/s12026-019-09100-z.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Allografts*
  • Colitis, Ulcerative* / genetics
  • Colitis, Ulcerative* / immunology
  • Colitis, Ulcerative* / pathology
  • Colitis, Ulcerative* / therapy
  • Ectodermal Dysplasia* / genetics
  • Ectodermal Dysplasia* / immunology
  • Ectodermal Dysplasia* / pathology
  • Ectodermal Dysplasia* / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • I-kappa B Kinase* / deficiency
  • I-kappa B Kinase* / immunology
  • Infant
  • Infliximab / administration & dosage*
  • Male
  • Primary Immunodeficiency Diseases* / genetics
  • Primary Immunodeficiency Diseases* / immunology
  • Primary Immunodeficiency Diseases* / pathology
  • Primary Immunodeficiency Diseases* / therapy

Substances

  • IKBKG protein, human
  • Infliximab
  • I-kappa B Kinase